Antibody–drug conjugates (ADCs) consist of three components: a monoclonal antibody, a linker, and a cytotoxic payload. The antibody is responsible for recognizing tumor-associated antigens, the payload is responsible for killing cells, and the linker determines whether the payload can be ...
Topic
ADC linker
Techniques for detecting, quantifying and localizing antigens and antibodies — ELISA, Western blotting, immunohistochemistry and flow cytometry. Below are the protocols, FAQs and technical articles in our knowledge base tagged with this topic.
2 resources · protocols, FAQs & articles
Antibo-drug conjugate (ADCs) combines the high specificity of antibodies with the strong cytotoxicity of small-molecule drugs. This combination combines the antibody's unique and very sensitive targeting ability to distinguish between healthy and cancerous tissue. It also has the cell-killing ...
Related topics
Techniques often explored alongside immunological experiments.